- Presentations
- 3
- Markets
- 1
Starjemza is a brand of Ustekinumab marketed by Hikma Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Ustekinumab
- Brand owner
- Hikma Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 130 mg/26 mL injection, 45 mg/0.5 mL injection, 90 mg/1 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Starjemza 130 mg/26 mL injectionIntravenous Cold chain | Hikma Pharmaceuticals | US FDA | Available on request |
| Starjemza 45 mg/0.5 mL injectionSubcutaneous Cold chain | Hikma Pharmaceuticals | US FDA | Available on request |
| Starjemza 90 mg/1 mL injectionSubcutaneous Cold chain | Hikma Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Ustekinumab.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Starjemza
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.